Vinblastine, sold under the brand name Velban. It is used to treat Hodgkin's disease, certain types of lymphoma, testicular cancer, breast cancer, choriocarcinoma, Kaposi's sarcoma, and Letterer-Siwe disease. Reference standards of Vinblastine API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Anhydro Vinblastine-d3 Disulfate Salt
Catalogue No.:PA STI 088182
CAS :
Molecular Formula : C46H57D3N4O16S2
Molecular Weight : 992.13
Catharanthine-d3
Catalogue No.:PA STI 088183
Molecular Formula : C21H21D3N2O2
Molecular Weight : 339.45
Deacetylvinblastine Hydrazide Sulfate-d3
Catalogue No.:PA STI 088184
Molecular Formula : C43H55D3N6O11S
Molecular Weight : 870.04
Deacetylvinblastine Hydrazide Sulfate-d3, 15N2
Catalogue No.:PA STI 088185
Molecular Formula : C43H55D3N415N2O11S
Molecular Weight : 872.02
Desacetylvinblastine (D0480000)
Catalogue No.:PA EPD0480000
Molecular Formula : NA
Molecular Weight : NA
Vinblastine Sulfate (JP 0247)
Catalogue No.:PA JP0247
Vinblastine sulfate (V0300000)
Catalogue No.:PA EPV0300000
Vinblastine sulfate - reference spectrum (V0305000)
Catalogue No.:PA EPV0305000
Catalogue No.:PA USP1713004
Molecular Formula :
Vinblastine Methiodide
Catalogue No.:PA 22 45510
Molecular Formula : C47H61IN4O9
Molecular Weight : 952.9
Vinblastine N’b-Oxide Maleic Acid Salt
Catalogue No.:PA 22 45520
Molecular Formula : C50H62N4O14
Molecular Weight : 943.05
Vinblastine
Catalogue No.:PA 22 0860000
Molecular Formula : C46H58N4O9
Molecular Weight : 810.99
Catharanthine Tartrate
Catalogue No.:PA 22 0861000
Molecular Formula : C25H30N2O8
Molecular Weight : 486.52
(5S,7R,9S)-9-((3aR,3a1R,4R,5S,5aR,10bR)-4-Acetoxy-3a-ethyl-5-hydroxy-8-methoxy-5-(methoxycarbonyl)-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazol-9-yl)-3-(chloromethyl)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,2,3,4,5,6,7,8,9,10-decahydro-3,7-methano[1]azacycloundecino[5,4-b]indol-3-ium Chloride
Catalogue No.:PA 22 0861001
Molecular Formula : C47H60Cl2N4O9
Molecular Weight : 895.92
Vinblastine N-oxide
Catalogue No.:PA 22 0861002
Molecular Formula : C46H58N4O10
Molecular Weight : 826.99
(3aR,3a1R,4R,5S,5aR,10bR)-4-Acetoxy-3a-ethyl-9-((5S,7R,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylic acid
Catalogue No.:PA 22 0861003
Molecular Formula : C45H56N4O9
Molecular Weight : 796.96
Methyl (3aR,3a1R,4R,5S,5aR,10bR)-4-acetoxy-3a-ethyl-9-((5S,7R,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-15-oxo-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylate
Catalogue No.:PA 22 0861004
Molecular Formula : C46H56N4O10
Molecular Weight : 824.97
(5S,7R,9S)-9-((3aR,3a1R,4R,5S,5aR,10bR)-4-Acetoxy-3a-ethyl-5-hydroxy-8-methoxy-5-(methoxycarbonyl)-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazol-9-yl)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-3-methyl-1,2,3,4,5,6,7,8,9,10-decahydro-3,7-methano[1]azacycloundecino[5,4-b]indol-3-ium iodide
Catalogue No.:PA 22 0861005
Molecular Weight : 952.93
Vinamidine
Catalogue No.:PA 22 0861006
Deacetoxyvinblastine
Catalogue No.:PA 22 0861007
Molecular Formula : C44H56N4O7
Molecular Weight : 752.95
Methyl (3aS,3a1R,4R,5S,5aR,10bR)-4-acetoxy-3a-ethyl-9-((5S,7R,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-8-methoxy-6-methyl-3a,4,5a,6,11,12-hexahydro-3H-3,5-epoxyindolizino[8,1-cd]carbazole-5(3a1H)-carboxylate
Catalogue No.:PA 22 0861008
Molecular Formula : C46H56N4O9
Molecular Weight : 808.97
Cyclovinblastine
Catalogue No.:PA 22 0861009
21'-O-Methyl Vinblastine
Catalogue No.:PA 22 0861010
Molecular Formula : C47H60N4O10
Molecular Weight : 841.02
Anhydro Vinblastinoic Acid Impurity
Catalogue No.:PA 22 0861011
Molecular Formula : C45H54N4O8
Molecular Weight : 778.95
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....